Overall survival (OS) with encorafenib (enco) plus cetuximab (cetux) in BEACON CRC: Effect of prior therapy for BRAF V600E-mutant metastatic colorectal cancer (mCRC)
Kopetz, S., Aderka, D., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H. S., . . . Tabernero, J. (2021). … Read More
